col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


107 Results       Page 1

 [1] 
Springer Science and Business Media LLC: Communications Biology
  original article Date Title Authors   All Authors
1 [GO] 2022―Nov―12 Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants Hristo L. Svilenov, Romina Bester, Julia Sacherl, Ramona Absmeier, Carsten Peters, Ulrike Protzer, et al. (+2)
2 [GO] 2022―Nov―10 Electron cryotomography of SARS-CoV-2 virions reveals cylinder-shaped particles with a double layer RNP assembly Lesley J. Calder, Thomas Calcraft, Saira Hussain, Ruth Harvey, Peter B. Rosenthal
3 [GO] 2022―Nov―05 ACE2 N-glycosylation modulates interactions with SARS-CoV-2 spike protein in a site-specific manner Ayana Isobe, Yasuha Arai, Daisuke Kuroda, Nobuaki Okumura, Takao Ono, Shota Ushiba, et al. (+6)
4 [GO] 2022―Nov―03 SARS-CoV-2 spike opening dynamics and energetics reveal the individual roles of glycans and their collective impact Yui Tik Pang, Atanu Acharya, Diane L. Lynch, Anna Pavlova, James C. Gumbart
5 [GO] 2022―Nov―02 Author Correction: Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture Zixuan Yuan, Mahmud Arif Pavel, Hao Wang, Jerome C. Kwachukwu, Sonia Mediouni, Joseph Anthony Jablonski, et al. (+4)
6 [GO] 2022―Oct―27 Evolution of naturally arising SARS-CoV-2 defective interfering particles Samer Girgis, Zaikun Xu, Spyros Oikonomopoulos, Alla D. Fedorova, Egor P. Tchesnokov, Calvin J. Gordon, et al. (+7)
7 [GO] 2022―Oct―27 SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model Christin Mache, Jessica Schulze, Gudrun Holland, Daniel Bourquain, Jean-Marc Gensch, Djin-Ye Oh, et al. (+4)
8 [GO] 2022―Oct―26 An explainable model of host genetic interactions linked to COVID-19 severity Anthony Onoja, Nicola Picchiotti, Chiara Fallerini, Margherita Baldassarri, Francesca Fava, Francesca Mari, et al. (+196)
9 [GO] 2022―Oct―17 Host adaptive mutations in the 2009 H1N1 pandemic influenza A virus PA gene regulate translation efficiency of viral mRNAs via GRSF1 Michael Lutz, Jordana Schmierer, Toru Takimoto
10 [GO] 2022―Oct―16 Cell-impermeable staurosporine analog targets extracellular kinases to inhibit HSV and SARS-CoV-2 Natalia Cheshenko, Jeffrey B. Bonanno, Hans-Heinrich Hoffmann, Rohit K. Jangra, Kartik Chandran, Charles M. Rice, et al. (+2)
11 [GO] 2022―Oct―10 Dynamic SARS-CoV-2 emergence algorithm for rationally-designed logical next-generation vaccines David P. Maison, Lauren L. Ching, Sean B. Cleveland, Alanna C. Tseng, Eileen Nakano, Cecilia M. Shikuma, Vivek R. Nerurkar
12 [GO] 2022―Sep―30 SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis Jun-yi Zhu, Guanglei Wang, Xiaohu Huang, Hangnoh Lee, Jin-Gu Lee, Penghua Yang, et al. (+5)
13 [GO] 2022―Sep―27 Publisher Correction: Reply to: How many SARS-CoV-2 “viroporins” are really ion channels? Trine L. Toft-Bertelsen, Mads Gravers Jeppesen, Asante Landbrug, Amer Mujezinovic, Bo Hjorth Bentzen, Thomas Nitschke Kledal, Mette Marie Rosenkilde
14 [GO] 2022―Sep―16 Autoprocessing and oxyanion loop reorganization upon GC373 and nirmatrelvir binding of monomeric SARS-CoV-2 main protease catalytic domain Nashaat T. Nashed, Daniel W. Kneller, Leighton Coates, Rodolfo Ghirlando, Annie Aniana, Andrey Kovalevsky, John M. Louis
15 [GO] 2022―Sep―15 Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture Zixuan Yuan, Mahmud Arif Pavel, Hao Wang, Jerome C. Kwachukwu, Sonia Mediouni, Joseph Anthony Jablonski, et al. (+4)
16 [GO] 2022―Sep―09 Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models Martin A. Rossotti, Henk van Faassen, Anh T. Tran, Joey Sheff, Jagdeep K. Sandhu, Diana Duque, et al. (+15)
17 [GO] 2022―Sep―07 Multiscale characterization reveals oligomerization dependent phase separation of primer-independent RNA polymerase nsp8 from SARS-CoV-2 Jinxin Xu, Xin Jiang, Yulong Zhang, Yan Dong, Changli Ma, Hanqiu Jiang, et al. (+6)
18 [GO] 2022―Sep―06 HLA alleles, disease severity, and age associate with T-cell responses following infection with SARS-CoV-2 Thorunn A. Olafsdottir, Kristbjorg Bjarnadottir, Gudmundur L. Norddahl, Gisli H. Halldorsson, Pall Melsted, Kristbjorg Gunnarsdottir, et al. (+25)
19 [GO] 2022―Sep―02 Spike-based adenovirus vectored COVID-19 vaccine does not aggravate heart damage after ischemic injury in mice Shanshan Gu, Zhongyan Chen, Xiangfu Meng, Ge Liu, He Xu, Liying Huang, et al. (+12)
20 [GO] 2022―Sep―02 Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations Claudia Maria Trombetta, Giulia Piccini, Giulio Pierleoni, Margherita Leonardi, Francesca Dapporto, Serena Marchi, et al. (+15)
21 [GO] 2022―Aug―25 Reply to: How Many SARS-CoV-2 “Viroporins” Are Really Ion Channels? Trine L. Toft-Bertelsen, Mads Gravers Jeppesen, Asante Landbrug, Amer Mujezinovic, Bo Hjorth Bentzen, Thomas Nitschke Kledal, Mette Marie Rosenkilde
22 [GO] 2022―Aug―25 How many SARS-CoV-2 “viroporins” are really ion channels? Neil L. Harrison, Geoffrey W. Abbott, Martina Gentzsch, Andrei Aleksandrov, Anna Moroni, Gerhard Thiel, et al. (+7)
23 [GO] 2022―Aug―17 The spike of SARS-CoV-2 promotes metabolic rewiring in hepatocytes Maria Mercado-Gómez, Endika Prieto-Fernández, Naroa Goikoetxea-Usandizaga, Laura Vila-Vecilla, Mikel Azkargorta, Miren Bravo, et al. (+20)
24 [GO] 2022―Aug―12 PIKfyve-specific inhibitors restrict replication of multiple coronaviruses in vitro but not in a murine model of COVID-19 James Logue, Arup R. Chakraborty, Robert Johnson, Girija Goyal, Melissa Rodas, Louis J. Taylor, et al. (+12)
25 [GO] 2022―Aug―12 Modeling SARS-CoV-2 and influenza infections and antiviral treatments in human lung epithelial tissue equivalents Hoda Zarkoob, Anna Allué-Guardia, Yu-Chi Chen, Andreu Garcia-Vilanova, Olive Jung, Steven Coon, et al. (+17)
26 [GO] 2022―Aug―11 Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease Vasundara Srinivasan, Hévila Brognaro, Prince R. Prabhu, Edmarcia Elisa de Souza, Sebastian Günther, Patrick Y. A. Reinke, et al. (+45)
27 [GO] 2022―Aug―06 mRNA booster vaccination protects aged mice against the SARS-CoV-2 Omicron variant Etsuro Nanishi, Marisa E. McGrath, Timothy R. O’Meara, Soumik Barman, Jingyou Yu, Huahua Wan, et al. (+15)
28 [GO] 2022―Aug―05 Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies Ruofan Li, Michael Mor, Bingting Ma, Alex E. Clark, Joel Alter, Michal Werbner, et al. (+8)
29 [GO] 2022―Jul―29 Human antibodies to SARS-CoV-2 with a recurring YYDRxG motif retain binding and neutralization to variants of concern including Omicron Hejun Liu, Chengzi I. Kaku, Ge Song, Meng Yuan, Raiees Andrabi, Dennis R. Burton, et al. (+2)
30 [GO] 2022―Jul―16 Identification of a guanine-specific pocket in the protein N of SARS-CoV-2 J. Rafael Ciges-Tomas, María Luisa Franco, Marçal Vilar
31 [GO] 2022―Jul―08 Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture Lukas Wettstein, Philip Maximilian Knaff, Christian Kersten, Patrick Müller, Tatjana Weil, Carina Conzelmann, et al. (+8)
32 [GO] 2022―Jul―06 A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron Ryota Maeda, Junso Fujita, Yoshinobu Konishi, Yasuhiro Kazuma, Hiroyuki Yamazaki, Itsuki Anzai, et al. (+15)
33 [GO] 2022―Jul―05 Altered subgenomic RNA abundance provides unique insight into SARS-CoV-2 B.1.1.7/Alpha variant infections Matthew D. Parker, Hazel Stewart, Ola M. Shehata, Benjamin B. Lindsey, Dhruv R. Shah, Sharon Hsu, et al. (+32)
34 [GO] 2022―Jul―01 Amino acid sensor GCN2 promotes SARS-CoV-2 receptor ACE2 expression in response to amino acid deprivation Xiaoming Hu, Yuguo Niu, Peixiang Luo, Fei Xiao, Feixiang Yuan, Hanrui Yin, et al. (+2)
35 [GO] 2022―Jun―16 Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia Domenico Lo Tartaro, Anita Neroni, Annamaria Paolini, Rebecca Borella, Marco Mattioli, Lucia Fidanza, et al. (+19)
36 [GO] 2022―Jun―03 Detection of SARS-CoV-2 in subcutaneous fat but not visceral fat, and the disruption of fat lymphocyte homeostasis in both fat tissues in the macaque Anaëlle Olivo, Romain Marlin, Thierry Lazure, Pauline Maisonnasse, Laetitia Bossevot, Christelliah Mouanga, et al. (+7)
37 [GO] 2022―May―30 Genomic determinants of Furin cleavage in diverse European SARS-related bat coronaviruses Anna-Lena Sander, Andres Moreira-Soto, Stoian Yordanov, Ivan Toplak, Andrea Balboni, Ramón Seage Ameneiros, et al. (+3)
38 [GO] 2022―May―30 Cell response analysis in SARS-CoV-2 infected bronchial organoids Emi Sano, Tatsuya Suzuki, Rina Hashimoto, Yumi Itoh, Ayaka Sakamoto, Yusuke Sakai, et al. (+14)
39 [GO] 2022―May―26 Automated amplification-free digital RNA detection platform for rapid and sensitive SARS-CoV-2 diagnosis Hajime Shinoda, Tatsuya Iida, Asami Makino, Mami Yoshimura, Junichiro Ishikawa, Jun Ando, et al. (+11)
40 [GO] 2022―May―19 SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication Yoichi Miyamoto, Yumi Itoh, Tatsuya Suzuki, Tomohisa Tanaka, Yusuke Sakai, Masaru Koido, et al. (+9)
41 [GO] 2022―May―11 Combining genomic and epidemiological data to compare the transmissibility of SARS-CoV-2 variants Alpha and Iota Mary E. Petrone, Jessica E. Rothman, Mallery I. Breban, Isabel M. Ott, Alexis Russell, Erica Lasek-Nesselquist, et al. (+42)
42 [GO] 2022―May―03 Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients Diego Cantoni, Martin Mayora-Neto, Nazia Thakur, Ahmed M. E. Elrefaey, Joseph Newman, Sneha Vishwanath, et al. (+9)
43 [GO] 2022―Apr―27 A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition Emmanuel Heilmann, Francesco Costacurta, Stephan Geley, Seyad Arad Mogadashi, Andre Volland, Bernhard Rupp, et al. (+2)
44 [GO] 2022―Mar―29 Statistical modeling of SARS-CoV-2 substitution processes: predicting the next variant Keren Levinstein Hallak, Saharon Rosset
45 [GO] 2022―Mar―25 Antibody-dependent enhancement (ADE) of SARS-CoV-2 pseudoviral infection requires FcγRIIB and virus-antibody complex with bivalent interaction Shuang Wang, Junchao Wang, Xiaojuan Yu, Wen Jiang, Shuo Chen, Rongjuan Wang, et al. (+17)
46 [GO] 2022―Mar―18 Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice Alvaro A. Ordonez, C. Korin Bullen, Andres F. Villabona-Rueda, Elizabeth A. Thompson, Mitchell L. Turner, Vanessa F. Merino, et al. (+9)
47 [GO] 2022―Mar―10 The SARS-CoV-2 Alpha variant exhibits comparable fitness to the D614G strain in a Syrian hamster model Maxime Cochin, Léa Luciani, Franck Touret, Jean-Sélim Driouich, Paul-Rémi Petit, Grégory Moureau, et al. (+8)
48 [GO] 2022―Mar―01 Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor Nashaat T. Nashed, Annie Aniana, Rodolfo Ghirlando, Sai Chaitanya Chiliveri, John M. Louis
49 [GO] 2022―Feb―25 Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay Anoop Narayanan, Manju Narwal, Sydney A. Majowicz, Carmine Varricchio, Shay A. Toner, Carlo Ballatore, et al. (+3)
50 [GO] 2022―Feb―22 Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture Xuanting Wang, Carolina Q. Sacramento, Steffen Jockusch, Otávio Augusto Chaves, Chuanjuan Tao, Natalia Fintelman-Rodrigues, et al. (+13)
51 [GO] 2022―Feb―08 An extended motif in the SARS-CoV-2 spike modulates binding and release of host coatomer in retrograde trafficking Debajit Dey, Suruchi Singh, Saif Khan, Matthew Martin, Nicholas J. Schnicker, Lokesh Gakhar, et al. (+2)
52 [GO] 2022―Jan―19 Tissue-level alveolar epithelium model for recapitulating SARS-CoV-2 infection and cellular plasticity Jia-Wei Yang, Yu-Rou Lin, Ying-Ling Chu, Johnson H. Y. Chung, Huai-En Lu, Guan-Yu Chen
53 [GO] 2022―Jan―12 SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB Christopher J. Neufeldt, Berati Cerikan, Mirko Cortese, Jamie Frankish, Ji-Young Lee, Agnieszka Plociennikowska, et al. (+16)
54 [GO] 2022―Jan―06 Inferring the stabilization effects of SARS-CoV-2 variants on the binding with ACE2 receptor Mattia Miotto, Lorenzo Di Rienzo, Giorgio Gosti, Leonardo Bo’, Giacomo Parisi, Roberta Piacentini, et al. (+3)
55 [GO] 2021―Dec―16 Deep dissection of the antiviral immune profile of patients with COVID-19 Djordje Atanackovic, Stephanie V. Avila, Forat Lutfi, Diego de Miguel-Perez, Xiaoxuan Fan, Gabriela Sanchez-Petitto, et al. (+14)
56 [GO] 2021―Dec―10 Author Correction: Amantadine inhibits known and novel ion channels encoded by SARS-CoV-2 in vitro Trine Lisberg Toft-Bertelsen, Mads Gravers Jeppesen, Eva Tzortzini, Kai Xue, Karin Giller, Stefan Becker, et al. (+6)
57 [GO] 2021―Dec―02 Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2 Kanako Shimizu, Tomonori Iyoda, An Sanpei, Hiroshi Nakazato, Masahiro Okada, Shogo Ueda, et al. (+6)
58 [GO] 2021―Dec―01 Amantadine has potential for the treatment of COVID-19 because it inhibits known and novel ion channels encoded by SARS-CoV-2 Trine Lisberg Toft-Bertelsen, Mads Gravers Jeppesen, Eva Tzortzini, Kai Xue, Karin Giller, Stefan Becker, et al. (+6)
59 [GO] 2021―Nov―30 Template switching and duplications in SARS-CoV-2 genomes give rise to insertion variants that merit monitoring Sofya K. Garushyants, Igor B. Rogozin, Eugene V. Koonin
60 [GO] 2021―Nov―22 High-resolution epitope mapping and characterization of SARS-CoV-2 antibodies in large cohorts of subjects with COVID-19 Winston A. Haynes, Kathy Kamath, Joel Bozekowski, Elisabeth Baum-Jones, Melissa Campbell, Arnau Casanovas-Massana, et al. (+79)
61 [GO] 2021―Nov―22 Spike protein multiorgan tropism suppressed by antibodies targeting SARS-CoV-2 Molly Brady, Conor McQuaid, Alexander Solorzano, Angelique Johnson, Abigail Combs, Chethana Venkatraman, et al. (+5)
62 [GO] 2021―Oct―28 Smoking is significantly associated with increased risk of COVID-19 and other respiratory infections Daniel B. Rosoff, Joyce Yoo, Falk W. Lohoff
63 [GO] 2021―Oct―22 Accurate detection and quantification of SARS-CoV-2 genomic and subgenomic mRNAs by ddPCR and meta-transcriptomics analysis Annarita Oranger, Caterina Manzari, Matteo Chiara, Elisabetta Notario, Bruno Fosso, Antonio Parisi, et al. (+5)
64 [GO] 2021―Oct―13 Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization Li Zhang, Zhimin Cui, Qianqian Li, Bo Wang, Yuanling Yu, Jiajing Wu, et al. (+11)
65 [GO] 2021―Sep―22 Emerging SARS-CoV-2 variants follow a historical pattern recorded in outgroups infecting non-human hosts Kazutaka Katoh, Daron M. Standley
66 [GO] 2021―Sep―20 Low dose inocula of SARS-CoV-2 Alpha variant transmits more efficiently than earlier variants in hamsters Bobo Wing-Yee Mok, Honglian Liu, Shaofeng Deng, Jiayan Liu, Anna Jinxia Zhang, Siu-Ying Lau, et al. (+13)
67 [GO] 2021―Aug―31 Trans-ethnic genome-wide association study of severe COVID-19 Peng Wu, Lin Ding, Xiaodong Li, Siyang Liu, Fanjun Cheng, Qing He, et al. (+53)
68 [GO] 2021―Aug―24 The structure of a dimeric form of SARS-CoV-2 polymerase Florian A. Jochheim, Dimitry Tegunov, Hauke S. Hillen, Jana Schmitzová, Goran Kokic, Christian Dienemann, Patrick Cramer
69 [GO] 2021―Aug―03 Identification, mapping and relative quantitation of SARS-CoV-2 Spike glycopeptides by Mass-Retention Time Fingerprinting Rod Chalk, William E. P. Greenland, Tiago Moreira, Jesse Coker, Shubhashish M. M. Mukhopadhyay, Eleanor Williams, et al. (+5)
70 [GO] 2021―Jul―29 Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection Thomas L. Williams, Maria T. Colzani, Robyn G. C. Macrae, Emma L. Robinson, Stuart Bloor, Edward J. D. Greenwood, et al. (+8)
71 [GO] 2021―Jul―26 ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models Teresa Lambe, Alexandra J. Spencer, Kelly M. Thomas, Karen E. Gooch, Stephen Thomas, Andrew D. White, et al. (+38)
72 [GO] 2021―Jul―22 “Be kind to yourself”: an interview with Sebastian Groh on being a transgender early career scientist during a global pandemic
73 [GO] 2021―Jul―15 Age-dependent appearance of SARS-CoV-2 entry sites in mouse chemosensory systems reflects COVID-19 anosmia-ageusia symptoms Julien Brechbühl, Ana Catarina Lopes, Dean Wood, Sofiane Bouteiller, Aurélie de Vallière, Chantal Verdumo, Marie-Christine Broillet
74 [GO] 2021―Jun―11 Structural basis of coronavirus E protein interactions with human PALS1 PDZ domain Airah Javorsky, Patrick O. Humbert, Marc Kvansakul
75 [GO] 2021―Jun―10 I(nsp1)ecting SARS-CoV-2-ribosome interactions Matthieu Simeoni, Théo Cavinato, Daniel Rodriguez, David Gatfield
76 [GO] 2021―Jun―03 The detection dogs test is more sensitive than real-time PCR in screening for SARS-CoV-2 Mohammed Hag-Ali, Abdul Salam AlShamsi, Linda Boeijen, Yasser Mahmmod, Rashid Manzoor, Harry Rutten, et al. (+3)
77 [GO] 2021―Jun―03 Single-nucleotide conservation state annotation of the SARS-CoV-2 genome Soo Bin Kwon, Jason Ernst
78 [GO] 2021―Jun―03 SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus Jungang Chen, Lu Dai, Lindsey Barrett, Jennifer James, Karlie Plaisance-Bonstaff, Steven R. Post, Zhiqiang Qin
79 [GO] 2021―May―19 Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization Shiho Chiba, Steven J. Frey, Peter J. Halfmann, Makoto Kuroda, Tadashi Maemura, Jie E. Yang, et al. (+3)
80 [GO] 2021―May―17 Genome-wide bioinformatic analyses predict key host and viral factors in SARS-CoV-2 pathogenesis Mariana G. Ferrarini, Avantika Lal, Rita Rebollo, Andreas J. Gruber, Andrea Guarracino, Itziar Martinez Gonzalez, et al. (+7)
81 [GO] 2021―Apr―23 Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2 Deyong Song, Wenbo Wang, Chuangchuang Dong, Zhenfei Ning, Xiu Liu, Chuan Liu, et al. (+17)
82 [GO] 2021―Apr―21 SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy Marta Giovanetti, Eleonora Cella, Francesca Benedetti, Brittany Rife Magalis, Vagner Fonseca, Silvia Fabris, et al. (+22)
83 [GO] 2021―Apr―20 Sensitive detection of SARS-CoV-2 seroconversion by flow cytometry reveals the presence of nucleoprotein-reactive antibodies in unexposed individuals Leire Egia-Mendikute, Alexandre Bosch, Endika Prieto-Fernández, So Young Lee, Borja Jiménez-Lasheras, Ana García del Río, et al. (+11)
84 [GO] 2021―Apr―13 Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical features Longxian Lv, Silan Gu, Huiyong Jiang, Ren Yan, Yanfei Chen, Yunbo Chen, et al. (+9)
85 [GO] 2021―Apr―12 Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2 Kushal Suryamohan, Devan Diwanji, Eric W. Stawiski, Ravi Gupta, Shane Miersch, Jiang Liu, et al. (+24)
86 [GO] 2021―Mar―22 Author Correction: An extended Weight Kernel Density Estimation model forecasts COVID-19 onset risk and identifies spatiotemporal variations of lockdown effects in China Wenzhong Shi, Chengzhuo Tong, Anshu Zhang, Bin Wang, Zhicheng Shi, Yepeng Yao, Peng Jia
87 [GO] 2021―Mar―09 Author Correction: Immunoreactive peptide maps of SARS-CoV-2 and other human coronaviruses Nischay Mishra, Xi Huang, Shreyas Joshi, Cheng Guo, James Ng, Riddhi Thakkar, et al. (+10)
88 [GO] 2021―Mar―05 IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection Bruce A. Rosa, Mushtaq Ahmed, Dhiraj K. Singh, José Alberto Choreño-Parra, Journey Cole, Luis Armando Jiménez-Álvarez, et al. (+10)
89 [GO] 2021―Mar―03 Author Correction: Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants Rui Wang, Jiahui Chen, Kaifu Gao, Yuta Hozumi, Changchuan Yin, Guo-Wei Wei
90 [GO] 2021―Feb―24 Limited window for donation of convalescent plasma with high live-virus neutralizing antibody titers for COVID-19 immunotherapy Abhinay Gontu, Sreenidhi Srinivasan, Eric Salazar, Meera Surendran Nair, Ruth H. Nissly, Denver Greenawalt, et al. (+21)
91 [GO] 2021―Feb―20 Temporal association between human upper respiratory and gut bacterial microbiomes during the course of COVID-19 in adults Rong Xu, Renfei Lu, Tao Zhang, Qunfu Wu, Weihua Cai, Xudong Han, et al. (+4)
92 [GO] 2021―Feb―17 Analysis of SARS-CoV-2 mutations in the United States suggests presence of four substrains and novel variants Rui Wang, Jiahui Chen, Kaifu Gao, Yuta Hozumi, Changchuan Yin, Guo-Wei Wei
93 [GO] 2021―Feb―12 Immunoreactive peptide maps of SARS-CoV-2 Nischay Mishra, Xi Huang, Shreyas Joshi, Cheng Guo, James Ng, Riddhi Thakkar, et al. (+10)
94 [GO] 2021―Feb―12 Human ACE2 peptide-mimics block SARS-CoV-2 pulmonary cells infection Philippe Karoyan, Vincent Vieillard, Luis Gómez-Morales, Estelle Odile, Amélie Guihot, Charles-Edouard Luyt, et al. (+3)
95 [GO] 2021―Feb―09 Tipiracil binds to uridine site and inhibits Nsp15 endoribonuclease NendoU from SARS-CoV-2 Youngchang Kim, Jacek Wower, Natalia Maltseva, Changsoo Chang, Robert Jedrzejczak, Mateusz Wilamowski, et al. (+5)
96 [GO] 2021―Jan―29 SARS-CoV-2 specific antibody and neutralization assays reveal the wide range of the humoral immune response to virus Mikail Dogan, Lina Kozhaya, Lindsey Placek, Courtney Gunter, Mesut Yigit, Rachel Hardy, et al. (+13)
97 [GO] 2021―Jan―27 Elucidating the tunability of binding behavior for the MERS-CoV macro domain with NAD metabolites Meng-Hsuan Lin, Chao-Cheng Cho, Yi-Chih Chiu, Chia-Yu Chien, Yi-Ping Huang, Chi-Fon Chang, Chun-Hua Hsu
98 [GO] 2021―Jan―25 An extended Weight Kernel Density Estimation model forecasts COVID-19 onset risk and identifies spatiotemporal variations of lockdown effects in China Wenzhong Shi, Chengzhuo Tong, Anshu Zhang, Bin Wang, Zhicheng Shi, Yepeng Yao, Peng Jia
99 [GO] 2021―Jan―20 Publisher Correction: Estimating and explaining the spread of COVID-19 at the county level in the USA Anthony R. Ives, Claudio Bozzuto
100 [GO] 2021―Jan―05 Estimating and explaining the spread of COVID-19 at the county level in the USA Anthony R. Ives, Claudio Bozzuto
101 [GO] 2021―Jan―04 Fast automated detection of COVID-19 from medical images using convolutional neural networks Shuang Liang, Huixiang Liu, Yu Gu, Xiuhua Guo, Hongjun Li, Li Li, et al. (+3)
102 [GO] 2020―Dec―11 The kinetics of humoral response and its relationship with the disease severity in COVID-19 Lili Ren, Lulu Zhang, De Chang, Junwen Wang, Yongfeng Hu, Hong Chen, et al. (+12)
103 [GO] 2020―Nov―23 Targeted intracellular degradation of SARS-CoV-2 via computationally optimized peptide fusions Pranam Chatterjee, Manvitha Ponnapati, Christian Kramme, Alexandru M. Plesa, George M. Church, Joseph M. Jacobson
104 [GO] 2020―Oct―27 Comparative ACE2 variation and primate COVID-19 risk Amanda D. Melin, Mareike C. Janiak, Frank Marrone, Paramjit S. Arora, James P. Higham
105 [GO] 2020―Oct―09 Systemic and respiratory T-cells induced by seasonal H1N1 influenza protect against pandemic H2N2 in ferrets Koen van de Ven, Femke de Heij, Harry van Dijken, José A. Ferreira, Jørgen de Jonge
106 [GO] 2020―Aug―18 Network pharmacology suggests biochemical rationale for treating COVID-19 symptoms with a Traditional Chinese Medicine Deng-hai Zhang, Xue Zhang, Bin Peng, Sheng-qiong Deng, Yu-fang Wang, Lin Yang, et al. (+3)
107 [GO] 2020―Jul―08 Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer Dimple Chakravarty, Sujit S. Nair, Nada Hammouda, Parita Ratnani, Yasmine Gharib, Vinayak Wagaskar, et al. (+5)
 [1] 

107 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.030 sec